牧原股份：千亿负债压顶，港股上市是续命还是冒险？

Core Viewpoint - The company, Muyuan Foods, faces significant financial challenges, including high debt levels, liquidity risks, and reliance on volatile pig prices, which could jeopardize its future performance and investor confidence [3][6][12]. Debt and Financial Structure - As of the end of 2024, the company's total liabilities reached 110.1 billion yuan, a decrease from the peak of 121.3 billion yuan in 2023, but short-term repayment pressures have increased [3]. - The company has 60.27 billion yuan in interest-bearing debt due within one year, marking a four-year high, with short-term loans amounting to 45.3 billion yuan and cash equivalents of only 12.8 billion yuan, resulting in a short-term repayment gap exceeding 32.5 billion yuan [3]. - The debt structure is characterized by a mismatch in maturity, with 70.3% of short-term loans, leading to a net current liability of 17.1 billion yuan [3][5]. Profitability and Cash Flow - In 2024, the company reported a net profit of 18.925 billion yuan, a 519% increase year-on-year, largely driven by a recovery in pig prices; however, a decline in average pig prices by 16.8% is expected in 2025, leading to a projected net profit drop to at least 15.1 billion yuan [6][8]. - The operating cash flow for 2024 was 37.5 billion yuan, but significant outflows from investment activities caused cash and cash equivalents to decrease from 19.4 billion yuan at the beginning of the year to 12.8 billion yuan by year-end [8]. - Concerns have been raised regarding the quality of earnings, with regulatory scrutiny highlighting discrepancies in cash management and insufficient provisions for inventory depreciation [8]. Market Position and Strategic Moves - The company's IPO on the Hong Kong Stock Exchange raised over 10 billion Hong Kong dollars, but the share price was set at 39 HKD, approximately 23.9% lower than its A-share price, reflecting market caution [9][11]. - The allocation of IPO proceeds includes 60% for overseas expansion, 30% for research and development, and 10% for working capital, raising concerns about the sustainability of this strategy given the existing debt burden [11]. - The company's international operations are still in the early stages, primarily involving technology transfer, and face various risks, including local policy challenges and disease control [11][12].